NEWAMSTERDAM PHARMA COMPANY NAMSW
*W EXP 11/22/202 · Equity WRT · CUSIP N62509117
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.35. Options: 1 managers hold calls ($65.0k notional), 0 hold puts (—).
Trends to Q4 2022
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2022 | $0 | $0 | — |
| Q4 2022 | $65.0k | $0 | 0.00 |
Biggest buyers
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | New | +705.4k |
| Frazier Life Sciences Management, L.P. | New | +500.3k |
| RA CAPITAL MANAGEMENT, L.P. | New | +333.3k |
| Alyeska Investment Group, L.P. | New | +285.1k |
| Ensign Peak Advisors, Inc | New | +150.0k |
| Exos TFP Holdings LLC | New | +137.3k |
| Bain Capital Life Sciences Investors, LLC | New | +100.0k |
| DEERFIELD MANAGEMENT COMPANY, L.P. | New | +92.8k |
| EcoR1 Capital, LLC | New | +66.7k |
| Castle Creek Arbitrage, LLC | New | +51.5k |
Biggest sellers
| None |
Biggest calls
| MILLENNIUM MANAGEMENT LLC | New | $65.0k75.0k shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Insider purchases and sales in Q4 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2022.
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC 0.02% of their portfolio | 705.4k $564.0k | New |
| Frazier Life Sciences Management, L.P. 0.03% of their portfolio | 500.3k $434.3k | New |
| RA CAPITAL MANAGEMENT, L.P. 0.01% of their portfolio | 333.3k $289.4k | New |
| Alyeska Investment Group, L.P. 0.02% of their portfolio | 285.1k $1.9m | New |
| Ensign Peak Advisors, Inc 0.00% of their portfolio | 150.0k $120.0k | New |
| Exos TFP Holdings LLC 0.03% of their portfolio | 137.3k $119.2k | New |
| Bain Capital Life Sciences Investors, LLC 0.01% of their portfolio | 100.0k $86.0k | New |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.00% of their portfolio | 92.8k $80.6k | New |
| EcoR1 Capital, LLC 0.02% of their portfolio | 66.7k $726.6k | New |
| Castle Creek Arbitrage, LLC 0.00% of their portfolio | 51.5k $43.0k | New |
| PEAK6 Investments LLC 0.00% of their portfolio | 40.0k $34.8k | New |
| Westchester Capital Management, LLC 0.00% of their portfolio | 31.2k $25.0k | New |
| HRT FINANCIAL LP 0.00% of their portfolio | 30.3k $24.0k | New |
| Walleye Capital LLC 0.00% of their portfolio | 28.4k $24.6k | New |
| CAXTON CORP 0.05% of their portfolio | 21.3k $17.8k | Not comparable |
| Laurion Capital Management LP 0.00% of their portfolio | 16.7k $13.3k | New |
| Walleye Trading LLC 0.00% of their portfolio | 16.4k $14.2k | New |
| Vestcor Inc 0.00% of their portfolio | 9.6k $8.0k | New |
| DUPONT CAPITAL MANAGEMENT CORP 0.00% of their portfolio | 8.3k $6.7k | New |
| Mint Tower Capital Management B.V. 0.00% of their portfolio | 6.5k $6.0k | New |
| WOLVERINE ASSET MANAGEMENT LLC 0.00% of their portfolio | 1.5k $1.3k | New |
| UBS Group AG 0.00% of their portfolio | 1.1k $936 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |